Home > Press Releases > Pharma Cold Chain Packaging Market

Pharma Cold Chain Packaging Market Likely to Surpass USD 18.6 Billion by 2035

Report Code: PKG-6081  |  Published in: Aug 2026, By MarketGenics  |  Number of pages: 288
Get PDF
Buy

Global Pharma Cold Chain Packaging Market Forecast 2035:

According to the report, the global pharma cold chain packaging market is likely to grow from USD 9.3 Billion in 2025 to USD 18.6 Billion in 2035 at a highest CAGR of 7.2% during the time period. The global pharma cold chain packaging market is progressing steadily with pharmaceutical companies, healthcare organizations and logistics companies increasingly prioritizing over maintaining product stability in complex temperature-controlled supply chains.

Advanced thermal packaging solutions such as passive shippers, active containers, and phase change materials, as well as insulated packaging formats to meet strict pharmaceutical handling requirements, are increasingly required to meet the demands of biologics, vaccines, cell and gene therapies, and specialty medicines.

The modernization of thermal materials, packaging technology, and shipment monitoring solutions is impacting the cold chain industry by improving temperature accuracy, minimizing product loss, and increasing transportation reliability. Organizations are funding research into new insulation materials, reusable packaging platforms and verified temperature-control solutions that allow for the efficient transport of high-value pharmaceutical products across the globe and the ability to adapt to changing regulations and quality standards.

The increasing adoption of connected cold chain ecosystems, sustainable packaging models, and customized temperature management solutions is strengthening market expansion across pharmaceutical manufacturing, clinical research, and healthcare distribution networks. All these developments are helping to make supply chains more resilient, to make them more efficient and to better safeguard temperature-sensitive medicines.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Pharma Cold Chain Packaging Market”

The global proliferation of biologics, vaccines, specialty medicines and advanced therapies is driving up the demand for pharma cold chain packaging solutions because pharmaceutical companies need to have validated thermal protection solutions that will ensure the efficacy of their products during storage and transportation. With the growing trend of global healthcare logistics, decentralised clinical trials and direct-to-patient medicine delivery, there is an ever greater demand for secure and temperature-controlled packaging solutions throughout the world.

Advanced temperature-controlled solutions are complicated to qualify, validate and maintain and have proven to be a challenge in the adoption of pharma cold chain packaging. Compliance with pharmaceutical regulations, as well as the requirement for manufacturers and logistics providers to undergo extensive thermal performance testing and operate in different transport environments are likely to extend development cycles, compliance costs and operational issues for packaging providers.

The increasing use of reusable thermal shippers, integrated monitoring and sustainable cold chain systems is opening new avenues for pharma cold chain packaging manufacturers. These advancements in phase change materials, IoT temperature monitoring, and returnable packaging are driving greater shipment visibility and minimizing packaging waste, along with optimizing logistics performance, for pharmaceutical companies and helping enhance global healthcare distribution networks.

Expansion of Global Pharma Cold Chain Packaging Market

“Advanced Thermal Engineering, Reusable Packaging Networks, and Digital Cold Chain Optimization”

  • The rise in the advanced thermal engineering solutions is giving rise to new growth opportunities in the pharma cold chain packaging market as more and more pharmaceutical companies are demanding high-performance packaging systems that can maintain a controlled temperature throughout the product's shelf-life, especially for biologics, vaccines, cell therapies and specialty medicines. Advancements in phase change material, vacuum insulation panel and next generation thermal design ensures shipment reliability and minimizes potential temperature excursions throughout global healthcare logistics networks.
  • The establishment of cold chain packaging networks that can be recycled by third parties is driving market growth by assisting pharmaceutical companies and logistics companies to streamline their operations, cut packaging waste, and carry out long-distance cold chain transportation more economically. The use of reusable shippers, rental packaging solutions and refurbishment schemes are helping to ensure more sustainable and cost-effective cold chain operations.
  • Digital monitoring systems, predictive analytics, and connected packaging are also opening new avenues for pharma cold chain packaging, providing greater visibility, temperature monitoring, risk management, and compliance in complex pharma distribution networks.

Regional Analysis of Global Pharma Cold Chain Packaging Market

  • North America dominates the pharma cold chain packaging market because of the well-developed biopharmaceutical manufacturing sector, robust healthcare logistics setup, and temperature-controlled distribution solutions adoption rate. The United States and Canada are leading the region by making significant strides in biologics and vaccine manufacturing, implementing GDP compliant cold chain practices, and ongoing investments in reusable thermal shippers, smart monitoring systems and validated packaging technologies for sensitive pharmaceutical products.
  • Asia Pacific is projected to be the fastest-growing pharma cold chain packaging market, owing to the growing pharmaceutical manufacturing capabilities, growing investments in the healthcare industry, and the rising demand for vaccines, biologics and specialty medicines. Pharmaceutical export expansion, building up cold chain facilities, adoption of modern thermal packaging technologies, etc. and government initiatives on the improvement of the reliability of the healthcare supply chain are driving market growth in countries such as China, India, Japan, and South Korea.

Prominent players operating in the global pharma cold chain packaging market are AeroSafe Global, Carrier Global Corporation, Cold Chain Technologies, Cryopak, Cryoport, Inc., CSafe, Dokasch Temperature Solutions GmbH, Envirotainer, Intelsius - A DGP Company, Nordic Cold Chain Solutions, Peli BioThermal LLC, Sofrigam Group, Softbox Systems India Pvt. Ltd., ThermoSafe, va-Q-tec Thermal Solutions GmbH, Other Key Players.

The global pharma cold chain packaging market has been segmented as follows:

Global Pharma Cold Chain Packaging Market Analysis, by Product Type

  • Insulated Shipping Containers
    • Small Boxes/Parcels
    • Large Containers/Pallet Shippers
  • Vaccine Carriers & Cold Boxes
  • Cold Packs, Gel Packs & Refrigerants
    • Gel Packs
    • Dry Ice
    • Eutectic/PCM Plates
  • Cryogenic Containers
  • Temperature Monitoring Devices/Data Loggers
  • Thermal Blankets & Wraps
  • Others

Global Pharma Cold Chain Packaging Market Analysis, by Material Type

  • Expanded Polystyrene
  • Polyurethane
  • Vacuum Insulated Panels
  • Corrugated Fiberboard
  • Molded Pulp
  • Plastic
  • Metal
  • Others

Global Pharma Cold Chain Packaging Market Analysis, by Temperature Range

  • Frozen (Below -20°C)
  • Cryogenic (Below -150°C)
  • Refrigerated (2°C to 8°C)
  • Controlled Room Temperature (15°C to 25°C)

Global Pharma Cold Chain Packaging Market Analysis, by Packaging Type

  • Reusable Packaging
  • Disposable Packaging

Global Pharma Cold Chain Packaging Market Analysis, by Mode of Transportation

  • Roadways
  • Airways
  • Seaways
  • Railways

Global Pharma Cold Chain Packaging Market Analysis, by Application

  • Vaccines
  • Biologics & Biosimilars
  • Blood & Blood Products
  • Clinical Trial Materials/Investigational Products
  • Organs, Tissues & Cell & Gene Therapies
  • Pharmaceuticals & Generic Drugs
  • Diagnostic Samples/IVD Reagents
  • Other Applications

Global Pharma Cold Chain Packaging Market Analysis, by End-Use Industry

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Diagnostic & Testing Laboratories
  • Research & Academic Institutes
  • Logistics & Distribution Companies/3PLs
  • Contract Manufacturing
  • Others

Global Pharma Cold Chain Packaging Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Pharma Cold Chain Packaging Market Outlook
      • 2.1.1. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Packaging Industry Overview, 2025
      • 3.1.1. Packaging Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Packaging Industry
      • 3.1.3. Regional Distribution for Packaging Industry
    • 3.2. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising demand for temperature-sensitive biologics, vaccines, and specialty pharmaceuticals.
        • 4.1.1.2. Expansion of global pharmaceutical cold chain logistics and distribution networks.
        • 4.1.1.3. Increasing regulatory focus on product integrity, temperature compliance, and safe drug transportation.
      • 4.1.2. Restraints
        • 4.1.2.1. High costs associated with advanced temperature-controlled packaging and cold chain operations.
        • 4.1.2.2. Complex qualification, validation, and regulatory compliance requirements for cold chain packaging systems.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Pharma Cold Chain Packaging Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Pharma Cold Chain Packaging Market Analysis, by Product Type
    • 6.1. Key Segment Analysis
    • 6.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 6.2.1. Insulated Shipping Containers
        • 6.2.1.1. Small Boxes/Parcels
        • 6.2.1.2. Large Containers/Pallet Shippers
      • 6.2.2. Vaccine Carriers & Cold Boxes
      • 6.2.3. Cold Packs, Gel Packs & Refrigerants
        • 6.2.3.1. Gel Packs
        • 6.2.3.2. Dry Ice
        • 6.2.3.3. Eutectic/PCM Plates
      • 6.2.4. Cryogenic Containers
      • 6.2.5. Temperature Monitoring Devices/Data Loggers
      • 6.2.6. Thermal Blankets & Wraps
      • 6.2.7. Others
  • 7. Global Pharma Cold Chain Packaging Market Analysis, by Material Type
    • 7.1. Key Segment Analysis
    • 7.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Material Type, 2021-2035
      • 7.2.1. Expanded Polystyrene
      • 7.2.2. Polyurethane
      • 7.2.3. Vacuum Insulated Panels
      • 7.2.4. Corrugated Fiberboard
      • 7.2.5. Molded Pulp
      • 7.2.6. Plastic
      • 7.2.7. Metal
      • 7.2.8. Others
  • 8. Global Pharma Cold Chain Packaging Market Analysis, by Temperature Range
    • 8.1. Key Segment Analysis
    • 8.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Temperature Range, 2021-2035
      • 8.2.1. Frozen (Below -20°C)
      • 8.2.2. Cryogenic (Below -150°C)
      • 8.2.3. Refrigerated (2°C to 8°C)
      • 8.2.4. Controlled Room Temperature (15°C to 25°C)
  • 9. Global Pharma Cold Chain Packaging Market Analysis, by Packaging Type
    • 9.1. Key Segment Analysis
    • 9.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Packaging Type, 2021-2035
      • 9.2.1. Reusable Packaging
      • 9.2.2. Disposable Packaging
  • 10. Global Pharma Cold Chain Packaging Market Analysis, by Mode of Transportation
    • 10.1. Key Segment Analysis
    • 10.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Mode of Transportation, 2021-2035
      • 10.2.1. Roadways
      • 10.2.2. Airways
      • 10.2.3. Seaways
      • 10.2.4. Railways
  • 11. Global Pharma Cold Chain Packaging Market Analysis, by Application
    • 11.1. Key Segment Analysis
    • 11.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 11.2.1. Vaccines
      • 11.2.2. Biologics & Biosimilars
      • 11.2.3. Blood & Blood Products
      • 11.2.4. Clinical Trial Materials/Investigational Products
      • 11.2.5. Organs, Tissues & Cell & Gene Therapies
      • 11.2.6. Pharmaceuticals & Generic Drugs
      • 11.2.7. Diagnostic Samples/IVD Reagents
      • 11.2.8. Other Applications
  • 12. Global Pharma Cold Chain Packaging Market Analysis, by End-Use Industry
    • 12.1. Key Segment Analysis
    • 12.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-Use Industry, 2021-2035
      • 12.2.1. Pharmaceutical & Biotechnology Companies
      • 12.2.2. Hospitals & Clinics
      • 12.2.3. Diagnostic & Testing Laboratories
      • 12.2.4. Research & Academic Institutes
      • 12.2.5. Logistics & Distribution Companies/3PLs
      • 12.2.6. Contract Manufacturing
      • 12.2.7. Others
  • 13. Global Pharma Cold Chain Packaging Market Analysis and Forecasts, by Region
    • 13.1. Key Findings
    • 13.2. Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 13.2.1. North America
      • 13.2.2. Europe
      • 13.2.3. Asia Pacific
      • 13.2.4. Middle East
      • 13.2.5. Africa
      • 13.2.6. South America
  • 14. North America Pharma Cold Chain Packaging Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. North America Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Product Type
      • 14.3.2. Material Type
      • 14.3.3. Temperature Range
      • 14.3.4. Packaging Type
      • 14.3.5. Mode of Transportation
      • 14.3.6. Application
      • 14.3.7. End-Use Industry
      • 14.3.8. Country
        • 14.3.8.1. USA
        • 14.3.8.2. Canada
        • 14.3.8.3. Mexico
    • 14.4. USA Pharma Cold Chain Packaging Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Product Type
      • 14.4.3. Material Type
      • 14.4.4. Temperature Range
      • 14.4.5. Packaging Type
      • 14.4.6. Mode of Transportation
      • 14.4.7. Application
      • 14.4.8. End-Use Industry
    • 14.5. Canada Pharma Cold Chain Packaging Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Product Type
      • 14.5.3. Material Type
      • 14.5.4. Temperature Range
      • 14.5.5. Packaging Type
      • 14.5.6. Mode of Transportation
      • 14.5.7. Application
      • 14.5.8. End-Use Industry
    • 14.6. Mexico Pharma Cold Chain Packaging Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Product Type
      • 14.6.3. Material Type
      • 14.6.4. Temperature Range
      • 14.6.5. Packaging Type
      • 14.6.6. Mode of Transportation
      • 14.6.7. Application
      • 14.6.8. End-Use Industry
  • 15. Europe Pharma Cold Chain Packaging Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Europe Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Product Type
      • 15.3.2. Material Type
      • 15.3.3. Temperature Range
      • 15.3.4. Packaging Type
      • 15.3.5. Mode of Transportation
      • 15.3.6. Application
      • 15.3.7. End-Use Industry
      • 15.3.8. Country
        • 15.3.8.1. Germany
        • 15.3.8.2. United Kingdom
        • 15.3.8.3. France
        • 15.3.8.4. Italy
        • 15.3.8.5. Spain
        • 15.3.8.6. Netherlands
        • 15.3.8.7. Nordic Countries
        • 15.3.8.8. Poland
        • 15.3.8.9. Russia & CIS
        • 15.3.8.10. Rest of Europe
    • 15.4. Germany Pharma Cold Chain Packaging Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Product Type
      • 15.4.3. Material Type
      • 15.4.4. Temperature Range
      • 15.4.5. Packaging Type
      • 15.4.6. Mode of Transportation
      • 15.4.7. Application
      • 15.4.8. End-Use Industry
    • 15.5. United Kingdom Pharma Cold Chain Packaging Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Product Type
      • 15.5.3. Material Type
      • 15.5.4. Temperature Range
      • 15.5.5. Packaging Type
      • 15.5.6. Mode of Transportation
      • 15.5.7. Application
      • 15.5.8. End-Use Industry
    • 15.6. France Pharma Cold Chain Packaging Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Product Type
      • 15.6.3. Material Type
      • 15.6.4. Temperature Range
      • 15.6.5. Packaging Type
      • 15.6.6. Mode of Transportation
      • 15.6.7. Application
      • 15.6.8. End-Use Industry
    • 15.7. Italy Pharma Cold Chain Packaging Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Product Type
      • 15.7.3. Material Type
      • 15.7.4. Temperature Range
      • 15.7.5. Packaging Type
      • 15.7.6. Mode of Transportation
      • 15.7.7. Application
      • 15.7.8. End-Use Industry
    • 15.8. Spain Pharma Cold Chain Packaging Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Product Type
      • 15.8.3. Material Type
      • 15.8.4. Temperature Range
      • 15.8.5. Packaging Type
      • 15.8.6. Mode of Transportation
      • 15.8.7. Application
      • 15.8.8. End-Use Industry
    • 15.9. Netherlands Pharma Cold Chain Packaging Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Product Type
      • 15.9.3. Material Type
      • 15.9.4. Temperature Range
      • 15.9.5. Packaging Type
      • 15.9.6. Mode of Transportation
      • 15.9.7. Application
      • 15.9.8. End-Use Industry
    • 15.10. Nordic Countries Pharma Cold Chain Packaging Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Product Type
      • 15.10.3. Material Type
      • 15.10.4. Temperature Range
      • 15.10.5. Packaging Type
      • 15.10.6. Mode of Transportation
      • 15.10.7. Application
      • 15.10.8. End-Use Industry
    • 15.11. Poland Pharma Cold Chain Packaging Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Product Type
      • 15.11.3. Material Type
      • 15.11.4. Temperature Range
      • 15.11.5. Packaging Type
      • 15.11.6. Mode of Transportation
      • 15.11.7. Application
      • 15.11.8. End-Use Industry
    • 15.12. Russia & CIS Pharma Cold Chain Packaging Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Product Type
      • 15.12.3. Material Type
      • 15.12.4. Temperature Range
      • 15.12.5. Packaging Type
      • 15.12.6. Mode of Transportation
      • 15.12.7. Application
      • 15.12.8. End-Use Industry
    • 15.13. Rest of Europe Pharma Cold Chain Packaging Market
      • 15.13.1. Country Segmental Analysis
      • 15.13.2. Product Type
      • 15.13.3. Material Type
      • 15.13.4. Temperature Range
      • 15.13.5. Packaging Type
      • 15.13.6. Mode of Transportation
      • 15.13.7. Application
      • 15.13.8. End-Use Industry
  • 16. Asia Pacific Pharma Cold Chain Packaging Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Asia Pacific Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Product Type
      • 16.3.2. Material Type
      • 16.3.3. Temperature Range
      • 16.3.4. Packaging Type
      • 16.3.5. Mode of Transportation
      • 16.3.6. Application
      • 16.3.7. End-Use Industry
      • 16.3.8. Country
        • 16.3.8.1. China
        • 16.3.8.2. India
        • 16.3.8.3. Japan
        • 16.3.8.4. South Korea
        • 16.3.8.5. Australia and New Zealand
        • 16.3.8.6. Indonesia
        • 16.3.8.7. Malaysia
        • 16.3.8.8. Thailand
        • 16.3.8.9. Vietnam
        • 16.3.8.10. Rest of Asia Pacific
    • 16.4. China Pharma Cold Chain Packaging Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Product Type
      • 16.4.3. Material Type
      • 16.4.4. Temperature Range
      • 16.4.5. Packaging Type
      • 16.4.6. Mode of Transportation
      • 16.4.7. Application
      • 16.4.8. End-Use Industry
    • 16.5. India Pharma Cold Chain Packaging Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Product Type
      • 16.5.3. Material Type
      • 16.5.4. Temperature Range
      • 16.5.5. Packaging Type
      • 16.5.6. Mode of Transportation
      • 16.5.7. Application
      • 16.5.8. End-Use Industry
    • 16.6. Japan Pharma Cold Chain Packaging Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Product Type
      • 16.6.3. Material Type
      • 16.6.4. Temperature Range
      • 16.6.5. Packaging Type
      • 16.6.6. Mode of Transportation
      • 16.6.7. Application
      • 16.6.8. End-Use Industry
    • 16.7. South Korea Pharma Cold Chain Packaging Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Product Type
      • 16.7.3. Material Type
      • 16.7.4. Temperature Range
      • 16.7.5. Packaging Type
      • 16.7.6. Mode of Transportation
      • 16.7.7. Application
      • 16.7.8. End-Use Industry
    • 16.8. Australia and New Zealand Pharma Cold Chain Packaging Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Product Type
      • 16.8.3. Material Type
      • 16.8.4. Temperature Range
      • 16.8.5. Packaging Type
      • 16.8.6. Mode of Transportation
      • 16.8.7. Application
      • 16.8.8. End-Use Industry
    • 16.9. Indonesia Pharma Cold Chain Packaging Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Product Type
      • 16.9.3. Material Type
      • 16.9.4. Temperature Range
      • 16.9.5. Packaging Type
      • 16.9.6. Mode of Transportation
      • 16.9.7. Application
      • 16.9.8. End-Use Industry
    • 16.10. Malaysia Pharma Cold Chain Packaging Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Product Type
      • 16.10.3. Material Type
      • 16.10.4. Temperature Range
      • 16.10.5. Packaging Type
      • 16.10.6. Mode of Transportation
      • 16.10.7. Application
      • 16.10.8. End-Use Industry
    • 16.11. Thailand Pharma Cold Chain Packaging Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Product Type
      • 16.11.3. Material Type
      • 16.11.4. Temperature Range
      • 16.11.5. Packaging Type
      • 16.11.6. Mode of Transportation
      • 16.11.7. Application
      • 16.11.8. End-Use Industry
    • 16.12. Vietnam Pharma Cold Chain Packaging Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Product Type
      • 16.12.3. Material Type
      • 16.12.4. Temperature Range
      • 16.12.5. Packaging Type
      • 16.12.6. Mode of Transportation
      • 16.12.7. Application
      • 16.12.8. End-Use Industry
    • 16.13. Rest of Asia Pacific Pharma Cold Chain Packaging Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Product Type
      • 16.13.3. Material Type
      • 16.13.4. Temperature Range
      • 16.13.5. Packaging Type
      • 16.13.6. Mode of Transportation
      • 16.13.7. Application
      • 16.13.8. End-Use Industry
  • 17. Middle East Pharma Cold Chain Packaging Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Middle East Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Product Type
      • 17.3.2. Material Type
      • 17.3.3. Temperature Range
      • 17.3.4. Packaging Type
      • 17.3.5. Mode of Transportation
      • 17.3.6. Application
      • 17.3.7. End-Use Industry
      • 17.3.8. Country
        • 17.3.8.1. Turkey
        • 17.3.8.2. UAE
        • 17.3.8.3. Saudi Arabia
        • 17.3.8.4. Israel
        • 17.3.8.5. Rest of Middle East
    • 17.4. Turkey Pharma Cold Chain Packaging Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Product Type
      • 17.4.3. Material Type
      • 17.4.4. Temperature Range
      • 17.4.5. Packaging Type
      • 17.4.6. Mode of Transportation
      • 17.4.7. Application
      • 17.4.8. End-Use Industry
    • 17.5. UAE Pharma Cold Chain Packaging Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Product Type
      • 17.5.3. Material Type
      • 17.5.4. Temperature Range
      • 17.5.5. Packaging Type
      • 17.5.6. Mode of Transportation
      • 17.5.7. Application
      • 17.5.8. End-Use Industry
    • 17.6. Saudi Arabia Pharma Cold Chain Packaging Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Product Type
      • 17.6.3. Material Type
      • 17.6.4. Temperature Range
      • 17.6.5. Packaging Type
      • 17.6.6. Mode of Transportation
      • 17.6.7. Application
      • 17.6.8. End-Use Industry
    • 17.7. Israel Pharma Cold Chain Packaging Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Product Type
      • 17.7.3. Material Type
      • 17.7.4. Temperature Range
      • 17.7.5. Packaging Type
      • 17.7.6. Mode of Transportation
      • 17.7.7. Application
      • 17.7.8. End-Use Industry
    • 17.8. Rest of Middle East Pharma Cold Chain Packaging Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Product Type
      • 17.8.3. Material Type
      • 17.8.4. Temperature Range
      • 17.8.5. Packaging Type
      • 17.8.6. Mode of Transportation
      • 17.8.7. Application
      • 17.8.8. End-Use Industry
  • 18. Africa Pharma Cold Chain Packaging Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Africa Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Product Type
      • 18.3.2. Material Type
      • 18.3.3. Temperature Range
      • 18.3.4. Packaging Type
      • 18.3.5. Mode of Transportation
      • 18.3.6. Application
      • 18.3.7. End-Use Industry
      • 18.3.8. Country
        • 18.3.8.1. South Africa
        • 18.3.8.2. Egypt
        • 18.3.8.3. Nigeria
        • 18.3.8.4. Algeria
        • 18.3.8.5. Rest of Africa
    • 18.4. South Africa Pharma Cold Chain Packaging Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Product Type
      • 18.4.3. Material Type
      • 18.4.4. Temperature Range
      • 18.4.5. Packaging Type
      • 18.4.6. Mode of Transportation
      • 18.4.7. Application
      • 18.4.8. End-Use Industry
    • 18.5. Egypt Pharma Cold Chain Packaging Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Product Type
      • 18.5.3. Material Type
      • 18.5.4. Temperature Range
      • 18.5.5. Packaging Type
      • 18.5.6. Mode of Transportation
      • 18.5.7. Application
      • 18.5.8. End-Use Industry
    • 18.6. Nigeria Pharma Cold Chain Packaging Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Product Type
      • 18.6.3. Material Type
      • 18.6.4. Temperature Range
      • 18.6.5. Packaging Type
      • 18.6.6. Mode of Transportation
      • 18.6.7. Application
      • 18.6.8. End-Use Industry
    • 18.7. Algeria Pharma Cold Chain Packaging Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Product Type
      • 18.7.3. Material Type
      • 18.7.4. Temperature Range
      • 18.7.5. Packaging Type
      • 18.7.6. Mode of Transportation
      • 18.7.7. Application
      • 18.7.8. End-Use Industry
    • 18.8. Rest of Africa Pharma Cold Chain Packaging Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Product Type
      • 18.8.3. Material Type
      • 18.8.4. Temperature Range
      • 18.8.5. Packaging Type
      • 18.8.6. Mode of Transportation
      • 18.8.7. Application
      • 18.8.8. End-Use Industry
  • 19. South America Pharma Cold Chain Packaging Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. South America Pharma Cold Chain Packaging Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Product Type
      • 19.3.2. Material Type
      • 19.3.3. Temperature Range
      • 19.3.4. Packaging Type
      • 19.3.5. Mode of Transportation
      • 19.3.6. Application
      • 19.3.7. End-Use Industry
      • 19.3.8. Country
        • 19.3.8.1. Brazil
        • 19.3.8.2. Argentina
        • 19.3.8.3. Rest of South America
    • 19.4. Brazil Pharma Cold Chain Packaging Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Product Type
      • 19.4.3. Material Type
      • 19.4.4. Temperature Range
      • 19.4.5. Packaging Type
      • 19.4.6. Mode of Transportation
      • 19.4.7. Application
      • 19.4.8. End-Use Industry
    • 19.5. Argentina Pharma Cold Chain Packaging Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Product Type
      • 19.5.3. Material Type
      • 19.5.4. Temperature Range
      • 19.5.5. Packaging Type
      • 19.5.6. Mode of Transportation
      • 19.5.7. Application
      • 19.5.8. End-Use Industry
    • 19.6. Rest of South America Pharma Cold Chain Packaging Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Product Type
      • 19.6.3. Material Type
      • 19.6.4. Temperature Range
      • 19.6.5. Packaging Type
      • 19.6.6. Mode of Transportation
      • 19.6.7. Application
      • 19.6.8. End-Use Industry
  • 20. Key Players/ Company Profile
    • 20.1. AeroSafe Global.
      • 20.1.1. Company Details/ Overview
      • 20.1.2. Company Financials
      • 20.1.3. Key Customers and Competitors
      • 20.1.4. Business/ Industry Portfolio
      • 20.1.5. Product Portfolio/ Specification Details
      • 20.1.6. Pricing Data
      • 20.1.7. Strategic Overview
      • 20.1.8. Recent Developments
    • 20.2. Carrier Global Corporation
    • 20.3. Cold Chain Technologies
    • 20.4. Cryopak
    • 20.5. Cryoport, Inc.
    • 20.6. CSafe
    • 20.7. Dokasch Temperature Solutions GmbH
    • 20.8. Envirotainer
    • 20.9. Intelsius - A DGP Company
    • 20.10. Nordic Cold Chain Solutions
    • 20.11. Other Key Players
    • 20.12. Peli BioThermal LLC
    • 20.13. Sofrigam Group
    • 20.14. Softbox Systems India Pvt. Ltd.
    • 20.15. ThermoSafe
    • 20.16. va-Q-tec Thermal Solutions GmbH
    • 20.17. Other Key Players

 

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

 

 

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation